S Douches - Concepedia

Concepedia

Author

S Douches

Armed Forces Institute of Pathology

Also Known As

S D Douches, S Douches, S. D. Douches, Susan D. Douches

13

Publications

1.3K

Citations

10

H-Index

34

Concepts

All Affiliations

Armed Forces Institute of Pathology Frederick National Laboratory for Cancer Research

SD

About

S Douches is an author at Armed Forces Institute of Pathology specializing in autoimmunity, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	843
2	Cell Biology	3	3	610
3	Health Sciences	1	1	146
4	Allergy	1	1	28
5	Cellular Therapies	1	1	146

S Douches

×

9

Publications

1.3K

Citations

9

H-Index

	Year	Citations
Interleukin 1 is a radioprotector. R Neta, S Douches, J J Oppenheim The Journal of Immunology Radiation EffectImmunologyCell DeathImmunologic MechanismLd100/17 Radiation Dose	1986	376
Interdependence of the radioprotective effects of human recombinant interleukin 1 <i>alpha</i> , tumor necrosis factor <i>alpha</i> , granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor. R Neta, Joost J. Oppenheim, S Douches The Journal of Immunology	1988	263
Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis. A J Hance, S Douches, R. J. Winchester, The Journal of Immunology Inflammatory Lung DiseaseLung InflammationImmunologyPulmonary Alveolar ProteinosisPathology	1985	156
The in vivo effects of interleukin 1. I. Bone marrow cells are induced to cycle after administration of interleukin 1. R Neta, Marcelo B. Sztein, J J Oppenheim, The Journal of Immunology Cell TherapyImmunologyInflammationHematologyBone Marrow	1987	146
Induction of colony stimulating factor in vivo by recombinant interleukin 1 <i>alpha</i> and recombinant tumor necrosis factor <i>alpha</i> 1. Stefanie N. Vogel, S Douches, Eric N. Kaufman, The Journal of Immunology	1987	144
Interaction of recombinant IL-1 and recombinant tumor necrosis factor in the induction of mouse acute phase proteins. Richard F. Mortensen, Joshua A. Shapiro, Baochuan Lin, The Journal of Immunology ImmunologyImmune RegulationCell DeathPathologyImmunologic Mechanism	1988	88
Cytokines in radioprotection. Comparison of the radioprotective effects of IL-1 to IL-2, GM-CSF and IFN gamma. R Neta, Simone Vogel, Joost J. Oppenheim, PubMed InflammationCytokineRadioprotective EffectsImmunotoxicologyIfn Gamma	1986	49
Enhanced Hematopoietic Recovery in Irradiated Mice Pretreated with Interleukin-1 (IL-1) Gretchen N. Schwartz, T J MacVittie, R. M. Vigneulle, Immunopharmacology and Immunotoxicology	1987	36
Tumor necrosis factor/cachectin is a less potent inducer of serum amyloid A synthesis than interleukin 1. Sipe Jd, Vogel Sn, S Douches, PubMed ImmunologyImmune RegulationPathologyCell DeathImmunotherapy	1987	28

Page 1